ArticleMedicina oral, patologia oral y cirugia bucal2026
Dental management of patients with cancer across the care pathway: A scoping review of clinical protocols.
Article in Medicina oral, patologia oral y cirugia bucal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral complications of cancer and its therapies impair quality of life and can disrupt oncologic care. Standardizing dental management across the care pathway is essential.
objectiveTo map operational protocols, guidelines, algorithms, or structured recommendations for dental management of oncology patients across pre-treatment, active treatment, and follow-up or survivorship from 2000 to 2025. MATERIAL AND
methodsScoping review according to JBI guidance and reported with PRISMA-ScR. Searches were run in PubMed or MEDLINE, SciELO, Scopus, Web of Science, and the Virtual Health Library on October 19, 2025, without language restrictions. Dual screening was performed in Rayyan. Data were charted in a standardized per-record matrix and synthesized narratively, in tables, and with graphics by care phase and oncologic modality. No formal critical appraisal or meta-analysis was undertaken.
resultsTwelve records were included. Coverage concentrated on pre-treatment (11 of 12; 91.7 percent), followed by follow-up or survivorship (6 of 12; 50.0 percent) and active treatment (3 of 12; 25.0 percent). Convergent recommendations included comprehensive pre-treatment assessment with sanitation, an intensified prevention bundle with hygiene instruction and topical fluorides, tooth-prognosis-based extraction criteria with defined healing windows, and supportive measures during therapy for mucositis, xerostomia, and infections. Gaps included limited standardization of survivorship pathways, insufficient personalization by oncologic modality (radiotherapy, chemotherapy, HSCT or CAR-T, immunotherapies), and scarce operational detail on safe timing windows, clinical or hematologic cutoffs, and referral or consultation triggers.
conclusionsEvidence supports an operational consensus for pre-treatment clearance and a core supportive bundle during therapy. To optimize safety and outcomes, particularly in middle-income settings, modality-specific protocols with explicit dentistry-oncology referral pathways, dose- and hematology-informed decision rules, and defined follow-up schedules are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.